Omeclamox-Pak

Cumberland Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 17, 2023
Approval ID: 9e52c29a-fdbe-4a4d-b280-d700eba5b94f
Products: 1 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OMECLAMOX-PAK safely and effectively. See full prescribing information for OMECLAMOX-PAK. OMECLAMOX-PAK (omeprazole delayed-release capsules; clarithromycin tablets, amoxicillin capsules) co-packaged for oral useInitial U.S. Approval: 2011

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.